Microorganism with enhanced L-lysine producibility and method for producing L-lysine using the same

US10676512B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10676512-B2
Application numberUS-201515508662-A
CountryUS
Kind codeB2
Filing dateSep 4, 2015
Priority dateSep 5, 2014
Publication dateJun 9, 2020
Grant dateJun 9, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present disclosure relates to a novel modified RNA polymerase sigma factor A (SigA) polypeptide; a polynucleotide encoding the same; a microorganism containing the polypeptide; and a method for producing L-lysine using the microorganism.

First claim

Opening claim text (preview).

The invention claimed is: 1. A modified polypeptide having RNA polymerase sigma factor A activity and the amino acid sequence set forth in SEQ ID NO: 2 but with one or two amino acid substitutions, wherein at least one of the one or two amino acid substitutions is selected from the group consisting of a substitution of the 136 th amino acid with glycine; a substitution of the 254 th amino acid with asparagine; a substitution of the 268 th amino acid with serine; a substitution of the 281 st amino acid with serine; a substitution of the 381 st amino acid with arginine; a substitution of the 429 th amino acid with arginine; a substitution of the 447 th amino acid with histidine; a substitution of the 451 st amino acid with isoleucine; a substitution of the 455 th amino acid with valine; a substitution of the 479 th amino acid with arginine; a substitution of the 483 rd amino acid with arginine; a substitution of the 488 th amino acid with threonine; and a substitution of the 491 st amino acid with arginine. 2. The modified polypeptide according to claim 1 , wherein the modified polypeptide has an amino acid sequence selected from the group consisting of the amino acid sequences set forth in SEQ ID NOS: 12 to 22. 3. A polynucleotide encoding the modified polypeptide of claim 1 . 4. A host cell comprising the polynucleotide of claim 3 . 5. A microorganism of the genus Corynebacterium having enhanced L-lysine producibility, comprising a modified polypeptide having RNA polymerase sigma factor A activity and the amino acid sequence set forth in SEQ ID NO: 2 but with one or two substitutions in SEQ ID NO:2, wherein at least one of the one or two substitutions is selected from the group consisting of a substitution of the 136 th amino acid with glycine; a substitution of the 254 th amino acid with asparagine; a substitution of the 268 th amino acid with serine; a substitution of the 281 st amino acid with serine; a substitution of the 381 st amino acid with arginine; a substitution of the 429 th amino acid with arginine; a substitution of the 447 th amino acid with histidine; a substitution of the 451 st amino acid with isoleucine; a substitution of the 455 th amino acid with valine; a substitution of the 479 th amino acid with arginine; a substitution of the 483 rd amino acid with arginine; a substitution of the 488 th amino acid with threonine; and a substitution of the 491 st amino acid with arginine. 6. The microorganism according to claim 5 , wherein the microorganism is Corynebacterium glutamicum. 7. A method for producing L-lysine, comprising: (a) culturing the microorganism according to claim 5 in a medium; and (b) recovering L-lysine from the cultured microorganism or the cultured medium.

Assignees

Inventors

Classifications

  • C07K14/34Primary

    from Corynebacterium (G) · CPC title

  • Lysine; Diaminopimelic acid; Threonine; Valine · CPC title

  • DNA-directed RNA polymerase (2.7.7.6) · CPC title

  • C12N9/12Primary

    transferring phosphorus containing groups, e.g. kinases (2.7) · CPC title

  • Chemistry & Metallurgy · mapped topic

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10676512B2 cover?
The present disclosure relates to a novel modified RNA polymerase sigma factor A (SigA) polypeptide; a polynucleotide encoding the same; a microorganism containing the polypeptide; and a method for producing L-lysine using the microorganism.
Who is the assignee on this patent?
Cj Cheiljedang Corp
What technology area does this patent fall under?
Primary CPC classification C07K14/34. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jun 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).